HPLC glycosaminoglycan analysis in patients with Graves' disease

Clinical Science

Volumn 92, Issue 5, 1997, Pages 511-517

  Hansen, Ch ^a   Fraiture, B ^a   Rouhi, R ^a   Otto, E ^a   Forster G ^a   Kahaly, G ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Anion exchange chromatography; Chondroitin sulphate A; Dermatan sulphate; Disaccharide analysis; Enzymic digestion; Hyaluronic acid

Indexed keywords

ACETIC ACID; ALCOHOL; CETYLPYRIDINIUM SALT; CHONDROITIN 4 SULFATE; CHONDROITIN ABC LYASE; DERMATAN SULFATE; DISACCHARIDE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; LYASE; PREDNISONE; STEROID;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; DRUG HYDROLYSIS; DRUG URINE LEVEL; EXOPHTHALMOS; FEMALE; FIBROBLAST; GRAVES DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; IRRADIATION; MAJOR CLINICAL STUDY; MALE; PRECIPITATION; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0030985883     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0920511     Document Type: Article

References (34)

1. Heinegard D, Paulsson N. Structure and metabolism of proteoglycans. In: Piez KA, Reddi AH, eds. Extracellular Matrix Biochemistry. New York: Elsevier, 1984: 277-328.
2. Poulsen JH. Urine and tissue glycosaminoglycans and their interrelations. Dan Med Bull 1986; 33: 75-96.
3. Elias JA, Krol RC, Freundlich B, Sampson PM. Regulation of human lung fibroblast glycosaminoglycan production by recombinant Interferon, tumor necrosis factor and lymphotoxin. J Clin Invest 1988; 81: 325-33.
4. lozzo RU. Proteoglycans: structure, function and role in neoplasia. Lab Invest 1985; 53: 373-95.
5. Ruoslahti E. Structure and biology of proteoglycans. Annu Rev Cell Biol 1988; 4: 229-55.
6. Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 1994; 15: 788-830.
7. Burch HB, Wartofsky L. Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocrinol Rev 1993; 14: 747-91.
8. Perros P, Cromble AL, Kendall-Taylor P. Natural history of thyroid associated ophthalmopathy. Clin Endocrinol 1995; 42: 45-50.
9. Weetman AP. Thyroid-associated eye disease: pathophysiology. Lancet 1991; 338: 25-8.
10. Smith TJ, Bahn RS, Gorman CA. Connective tissue, glycosaminoglycans, and disease of the thyroid. Endocrinol Rev 1989; 10: 366-91.
11. Kahaly G, Hansen C, Stover C, Kuhlemann K, Beyer j, Otto E. Glycosaminoglycans and endocrine orbitopathy. Exp Clin Endocrinol 1994; 102: 151-61.
12. Tan GH, Dutton CM, Bahn RS. Interleukin I (IL-1) receptor antagonist and soluble IL-I receptor inhibit IL-1 induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 1996; 81: 449-52.
13. Hansen Ch, Otto E, Kuhlemann K, Förster G, Kahaly GJ. Glycosaminoglycans in autoimmunity. Clin Exp Rheumatol 1996; 14: 59-67.
14. Blumenkrantz N, Asboe-Hansen G. New method for quantitative determination of uronic acids. Anal Biochem 1973; 54: 484-489.
15. Pennock CA. A review and selection of simple laboratory methods used for the study of glycosaminoglycan excretion and diagnosis of the mucopolysaccharidoses. J Clin Pathol 1976; 29: 111-23.
16. Yanagishita M, Midura RJ, Hascall VC. Proteoglycans: isolation and purification from tissue cultures. Methods Enzymol 1987; 138: 279-89.
17. Manley G, Severn M, Hawksworth J. Excretion patterns of glycosaminoglycans and glycoproteins in normal human urine. J Clin Pathol 1968; 21: 339-45.
18. Classification of eye changes of Graves' disease. Thyroid 1992; 2: 235-6.
19. Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol. 1989; 8: 639-44.
20. Kahaly G, Schuler M, Sewell, AC, Bernhard G, Beyer J, Krause U. Urinary glycosaminoglycans in Graves' ophthalmopathy. Clin Endocrinol 1990; 33: 35-44.
21. Bitter T, Muir HM. A modified uronic acid carbazole reaction. Anal Biochem 1962; 4: 330-4.
22. Stuhlsatz HW, Greiling H. The methodology of connective tissue research. In: Hall DA, ed. Oxford: Joynson-Bruvvers Ltd, 1976: 137-146.
23. Gurr E, Pallasch G, Tunn S, Tamm C, Delbrück A. high performance liquid Chromatographic assay of disaccharides and oligosaccharides produced by digestion of glycosaminoglycans with chondroitin sulphate lyases. J Clin Chem Clin Biochem 1985; 23: 77-87.
24. Gassler N, Reissner C, Janzen N, Kahnert H, Kleesiek K. A high performance liquid chromatography method for the determination of glycosaminoglycans in human blood. Eur J Clin Chem Clin Biochem 1993; 31: 503-11.
25. Winand RJ, Wadeleux PA. Glycosaminoglycans and orbital connective tissue autoantibodies. Acta Endocrinol 1989; 121: 51-5.
26. Kahaly G, Hansen C, Beyer J, Winand R. Plasma glycosaminoglycans in endocrine ophthalmopathy. J Endocrinol Invest 1994; 17: 45-50.
27. Kahaly G, Hansen CE, Stover C, Beyer J, Otto E. Glycosaminoglycan antibodies in endocrine ophthalmopathy. Horm Metab Res 1993; 25: 637-9.
28. Le Phuc Thuy, Nyhan WL. A new quantitative assay for glycosaminoglycans. Clin Chim Acta 1992; 212: 17-26.
29. Larking P. Quantitative gas Chromatographic measurement of glycosaminoglycan hexosamines in urine and plasma. J Chromatogr 1987; 420: 231-9.
30. Imai Y, Odajima R, Shimizu T, Shishiba Y. Serum hyaluronan concentration determined by radiometric assay in patients with pretibial myxedema and Graves' ophthalmopathy. Endocrinol Jpn 1990; 37: 749-52.
31. Silvestro L, Viano I, Naggi A, Torri G, Da Col R, Baiocchi C. High-performance liquid chromatographic-mass spectrometric analysis of oligosaccharides from enzymic digestion of glycosaminoglycans. Application to human samples. J Chromatogr 1992; 591: 225-32.
32. Muraca U, Vinci R, Ferlazzo AM, Muraca G, Calatroni A. Factors affecting glycosaminoglycan concentration in normal human plasma, Ital J Biochem 1992; 41: 159-69.
33. Fedarko NS, Vetter UK, Weinstein S, Robey PG. Age-related changes in hyaluronan, proteoglycan, collagen, and osteonectin synthesis by human bone cells. J Cell Physiol 1992; 151: 215-27.
34. Staprans I, Garon SJ, Hopper Jr J, Felts JM. Characterization of glycosaminoglycans in urine from patients with nephrotic syndrome and control subjects and their effects on lipoprotein lipase. Biochim Biophys Acta 1981; 678: 414-22.